Skip to main content
Premium Trial:

Request an Annual Quote

Kuniko Nishikawa

Analytics firm Fronteo Healthcare has chosen Kuniko Nishikawa as its new CEO. Nishikawa had been an independent director of the healthcare subsidiary of Tokyo-based Fronteo Inc. since December. She replaces previous CEO Naritomo Ikeue, who has agreed to remain on the board of directors, overseeing business development for Fronteo Healthcare. The company also named Masahiro Morimoto executive chairman. 

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.